Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Gemini Space Station Inc (GEMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Gemini Space Station Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.24 (market cap $30.93B), while Gemini Space Station Inc trades at $3.82 (market cap $500.46M). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 61.8× Gemini Space Station Inc's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Gemini Space Station Inc pays none. Which is the better fit depends on your goals.
| GEHC | GEMI | |
|---|---|---|
Market Cap | $30.93B | $500.46M |
Volume | 5,033,451 | 1,680,193 |
Sector | Health | Financials |
52-Week High | $88.16 | $22.36 |
52-Week Low | $59.48 | $3.54 |
Enterprise Value | $39.39B | $479.48M |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 15 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Gemini Space Station (GEMI) trades at $4.10, down 0.24% on the day, with a bearish technical signal despite recent price volatility. The company reported Q2 2026 revenue growth of 37% year-over-year but continues to post significant losses, with a net income margin of -250.13%. Recent news highlights expansion into commission-free stock trading and prediction markets, though the stock faces class action lawsuits and mixed analyst sentiment.
The outlook remains challenging due to persistent unprofitability and high cash burn, offset by revenue diversification efforts. Investment opportunities exist if the company achieves profitability and capitalizes on new market initiatives, but risks include ongoing losses, regulatory scrutiny, and competitive pressures in the trading platform space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →
